See also this year's filing and all EDGAR filings for this company.
PDF Report 0001785345_2022_Landos_Biopharma_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| info | NetIncome node detected by revenue/expenses heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'OperatingIncomeLoss'} |
| info | Ambiguous roles for statement | input.sec.calculation_linkbase.expand_agg | {'statement': 'operations', 'valid_roles': {'100030 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) 2': 2, '100040 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)': 8}} |
Graph
Absolute values for 0001785345, Landos Biopharma Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 92,146,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 707,000 |
| 3 | remainder_Assets | 26,000 |
| 4 | LiabilitiesCurrent | 16,611,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 15,252,000 |
| 9 | ResearchAndDevelopmentExpense | 41,564,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 18,000,000 |
| 12 | remainder_NetIncome | 0 |
| 13 | remainder_ComprehensiveNetIncome | 159,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 92,879,000 |
| 1 | Liabilities | 16,611,000 |
| 2 | Expenses | 56,816,000 |
| 3 | Revenues | 18,000,000 |
| 4 | StockholdersEquity | 76,268,000 |
| 5 | NetIncome | -38,816,000 |
| 6 | ComprehensiveNetIncome | -38,736,500 |
| 7 | BaseVar | 92,232,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.33 |
| 9 | EconomicCapitalRatio | 3.24 |
Edgar->Model Mapping
Feature Distribution
